Progress on Genetic Basis of Primary Aldosteronism
Primary aldosteronism (PA) is a heterogeneous group of disorders caused by the autonomous overproduction of aldosterone with simultaneous suppression of plasma renin activity (PRA). It is considered to be the most common endocrine cause of secondary arterial hypertension (HT) and is associated with...
Guardado en:
Autores principales: | , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/fa1f82f2f734431ab5daddcf1a8c0822 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:fa1f82f2f734431ab5daddcf1a8c0822 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:fa1f82f2f734431ab5daddcf1a8c08222021-11-25T16:51:05ZProgress on Genetic Basis of Primary Aldosteronism10.3390/biomedicines91117082227-9059https://doaj.org/article/fa1f82f2f734431ab5daddcf1a8c08222021-11-01T00:00:00Zhttps://www.mdpi.com/2227-9059/9/11/1708https://doaj.org/toc/2227-9059Primary aldosteronism (PA) is a heterogeneous group of disorders caused by the autonomous overproduction of aldosterone with simultaneous suppression of plasma renin activity (PRA). It is considered to be the most common endocrine cause of secondary arterial hypertension (HT) and is associated with a high rate of cardiovascular complications. PA is most often caused by a bilateral adrenal hyperplasia (BAH) or aldosterone-producing adenoma (APA); rarer causes of PA include genetic disorders of steroidogenesis (familial hyperaldosteronism (FA) type I, II, III and IV), aldosterone-producing adrenocortical carcinoma, and ectopic aldosterone-producing tumors. Over the last few years, significant progress has been made towards understanding the genetic basis of PA, classifying it as a channelopathy. Recently, a growing body of clinical evidence suggests that mutations in ion channels appear to be the major cause of aldosterone-producing adenomas, and several mutations within the ion channel encoding genes have been identified. Somatic mutations in four genes (<i>KCNJ5</i>, <i>ATP1A1</i>, <i>ATP2B3</i> and <i>CACNA1D</i>) have been identified in nearly 60% of the sporadic APAs, while germline mutations in <i>KCNJ5</i> and <i>CACNA1H</i> have been reported in different subtypes of familial hyperaldosteronism. These new insights into the molecular mechanisms underlying PA may be associated with potential implications for diagnosis and therapy.Izabela KarwackaŁukasz ObołończykSonia Kaniuka-JakubowskaMichał BohdanKrzysztof SworczakMDPI AGarticleprimary aldosteronismfamilial hyperaldosteronismion channelsaldosterone-producing adenoma<i>KCNJ5</i><i>ATP1A1</i>Biology (General)QH301-705.5ENBiomedicines, Vol 9, Iss 1708, p 1708 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
primary aldosteronism familial hyperaldosteronism ion channels aldosterone-producing adenoma <i>KCNJ5</i> <i>ATP1A1</i> Biology (General) QH301-705.5 |
spellingShingle |
primary aldosteronism familial hyperaldosteronism ion channels aldosterone-producing adenoma <i>KCNJ5</i> <i>ATP1A1</i> Biology (General) QH301-705.5 Izabela Karwacka Łukasz Obołończyk Sonia Kaniuka-Jakubowska Michał Bohdan Krzysztof Sworczak Progress on Genetic Basis of Primary Aldosteronism |
description |
Primary aldosteronism (PA) is a heterogeneous group of disorders caused by the autonomous overproduction of aldosterone with simultaneous suppression of plasma renin activity (PRA). It is considered to be the most common endocrine cause of secondary arterial hypertension (HT) and is associated with a high rate of cardiovascular complications. PA is most often caused by a bilateral adrenal hyperplasia (BAH) or aldosterone-producing adenoma (APA); rarer causes of PA include genetic disorders of steroidogenesis (familial hyperaldosteronism (FA) type I, II, III and IV), aldosterone-producing adrenocortical carcinoma, and ectopic aldosterone-producing tumors. Over the last few years, significant progress has been made towards understanding the genetic basis of PA, classifying it as a channelopathy. Recently, a growing body of clinical evidence suggests that mutations in ion channels appear to be the major cause of aldosterone-producing adenomas, and several mutations within the ion channel encoding genes have been identified. Somatic mutations in four genes (<i>KCNJ5</i>, <i>ATP1A1</i>, <i>ATP2B3</i> and <i>CACNA1D</i>) have been identified in nearly 60% of the sporadic APAs, while germline mutations in <i>KCNJ5</i> and <i>CACNA1H</i> have been reported in different subtypes of familial hyperaldosteronism. These new insights into the molecular mechanisms underlying PA may be associated with potential implications for diagnosis and therapy. |
format |
article |
author |
Izabela Karwacka Łukasz Obołończyk Sonia Kaniuka-Jakubowska Michał Bohdan Krzysztof Sworczak |
author_facet |
Izabela Karwacka Łukasz Obołończyk Sonia Kaniuka-Jakubowska Michał Bohdan Krzysztof Sworczak |
author_sort |
Izabela Karwacka |
title |
Progress on Genetic Basis of Primary Aldosteronism |
title_short |
Progress on Genetic Basis of Primary Aldosteronism |
title_full |
Progress on Genetic Basis of Primary Aldosteronism |
title_fullStr |
Progress on Genetic Basis of Primary Aldosteronism |
title_full_unstemmed |
Progress on Genetic Basis of Primary Aldosteronism |
title_sort |
progress on genetic basis of primary aldosteronism |
publisher |
MDPI AG |
publishDate |
2021 |
url |
https://doaj.org/article/fa1f82f2f734431ab5daddcf1a8c0822 |
work_keys_str_mv |
AT izabelakarwacka progressongeneticbasisofprimaryaldosteronism AT łukaszobołonczyk progressongeneticbasisofprimaryaldosteronism AT soniakaniukajakubowska progressongeneticbasisofprimaryaldosteronism AT michałbohdan progressongeneticbasisofprimaryaldosteronism AT krzysztofsworczak progressongeneticbasisofprimaryaldosteronism |
_version_ |
1718412934805192704 |